UNITED KINGDOM DATABASE STUDY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) FOR MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION

医学 黄斑水肿 眼压 视网膜静脉 眼科 视网膜中央静脉阻塞 视力 闭塞 视网膜分支静脉阻塞 青光眼 地塞米松 植入 白内障手术 外科 内科学
作者
Mohamed Kamel Soliman,Javier Zarranz‐Ventura,Usha Chakravarthy,Martin McKibbin,Christopher Brand,Geeta Menon,Helena Cilliers,Salim Natha,Adam H. Ross,Mahmoud Sarhan,Aires Lobo,Victor N. Chong,Sajjad Mahmood,Niaz Islam,Toks Akerele,Ahmed F. Shakarchi,Ahmed B. Sallam
出处
期刊:Retina-the Journal of Retinal and Vitreous Diseases [Lippincott Williams & Wilkins]
卷期号:43 (4): 679-687 被引量:17
标识
DOI:10.1097/iae.0000000000003698
摘要

PURPOSE: To study the treatment patterns, visual outcomes and safety profile of intravitreal dexamethasone implant (IDI) used for the treatment of macular edema secondary to retinal vein occlusion. METHODS: Up to 2 years of routinely collected anonymized data within electronic medical record systems were remotely extracted from 16 centers. The outcome measures include visual outcome, number of injections, and safety measures, including the rate of intraocular pressure (IOP) rise, frequency of IOP-lowering medication usage, and cataract surgery rates. RESULTS: The study included 688 eyes (44.4%) with central retinal vein occlusion and 862 eyes (55.6%) with branch retinal vein occlusion; 1,250 eyes (80.6%) were treatment naive and 28% (275/989) had high IOP or were on IOP-lowering medications before IDI use. It was found that 31% (476) of eyes received two injections, and 11.7% (182) and 3.7% (58) of eyes received three and four injections, respectively. The mean baseline Snellen visual acuity improved from 20/125 to 20/40 after the first injection. The probability of cataract surgery was 15% at 24 months. The proportion of eyes with ≥10 mmHg change from baseline was higher in phakic (14.2%) compared with pseudophakic eyes (5.4%, P = 0.004). Three eyes required IOP filtering surgery (0.2%). CONCLUSION: The visual results of IDI in eyes with macular edema secondary to retinal vein occlusion in the real world are comparable to those of clinical trial setting. Increased IOP in eyes with preexisting ocular hypertension or glaucoma can be controlled with additional medical treatment. Intraocular pressure rise with IDI may be more frequent in phakic than in pseudophakic eyes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
微信研友发布了新的文献求助10
刚刚
xhj666完成签到,获得积分10
刚刚
1秒前
JJyue发布了新的文献求助50
1秒前
wy完成签到,获得积分10
2秒前
arizaki7发布了新的文献求助10
3秒前
王一硕发布了新的文献求助10
3秒前
留蓝发布了新的文献求助10
4秒前
Owen的应助被夏梓硕采纳,获得10
4秒前
周林发布了新的文献求助10
5秒前
5秒前
wl完成签到,获得积分10
6秒前
humble发布了新的文献求助10
6秒前
羊羊羊完成签到,获得积分20
6秒前
白术完成签到,获得积分10
6秒前
8秒前
8秒前
jjj完成签到,获得积分10
9秒前
wanci的应助被Rauf采纳,获得10
9秒前
CHEN完成签到,获得积分10
10秒前
GIN的应助被胡萝卜卜采纳,获得10
10秒前
科研通AI6.4的应助被WYF1996采纳,获得10
11秒前
科研通AI65的应助被科研通管家采纳,获得10
11秒前
CipherSage的应助被科研通管家采纳,获得10
11秒前
大模型的应助被科研通管家采纳,获得10
11秒前
xlxl完成签到,获得积分10
11秒前
无极微光的应助被科研通管家采纳,获得20
11秒前
AAAA完成签到,获得积分10
11秒前
ding的应助被科研通管家采纳,获得10
11秒前
桐桐的应助被科研通管家采纳,获得10
11秒前
杜若完成签到,获得积分10
11秒前
酷波er的应助被科研通管家采纳,获得10
11秒前
12秒前
CipherSage的应助被科研通管家采纳,获得10
12秒前
JamesPei的应助被科研通管家采纳,获得10
12秒前
零负一的应助被科研通管家采纳,获得10
12秒前
自然的冥王星完成签到,获得积分10
12秒前
无极微光的应助被科研通管家采纳,获得20
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193348
求助须知:如何正确求助?哪些是违规求助? 9579548
关于积分的说明 21866040
捐赠科研通 7792906
什么是DOI,文献DOI怎么找? 3437242
关于科研通互助平台的介绍 2560702
邀请新用户注册赠送积分活动 2484066